Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Vaccines play a vital role in protecting the host against infectious disease. The most effective licensed vaccines elicit long-term antigen-specific antibody responses by plasma cells in addition to the development of persisting T cell and B cell memory. The relative contributions of these different immune cell subsets are context-dependent and vary depending on the attributes of the vaccine (i.e., live/attenuated, inactivated, and subunit) as well as the biology of the pathogen in question. For relatively simple vaccines against bacterial antigens (e.g., tetanus toxin) or invariant viruses, the immunological correlates of protection are well-characterized. For more complex vaccines against viruses, especially those that mutate or cause latent infections, it is more difficult to define the specific correlates of immunity. This often requires observational/natural history studies, clinical trials, or experimental evaluation in relevant animal models in order for immunological correlates to be determined or extrapolated. In this review, we will discuss the relative contributions of virus-specific T cell and B cell responses to vaccine-mediated protection against disease.

[1]  R. Ahmed,et al.  From vaccines to memory and back. , 2010, Immunity.

[2]  Alan D. Roberts,et al.  Activation phenotype, rather than central– or effector–memory phenotype, predicts the recall efficacy of memory CD8+ T cells , 2007, The Journal of experimental medicine.

[3]  N. Stollenwerk,et al.  Measles Outbreaks in a Population with Declining Vaccine Uptake , 2003, Science.

[4]  S. Plotkin Why certain vaccines have been delayed or not developed at all. , 2005, Health affairs.

[5]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[6]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[7]  C. Walker,et al.  Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans. , 1993, The Journal of general virology.

[8]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[9]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[10]  M. Slifka,et al.  Public fear of vaccination: separating fact from fiction. , 2005, Viral immunology.

[11]  F. Ennis,et al.  Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones , 1992, Journal of virology.

[12]  Boris Katz,et al.  The 2009 COID Recommendations for RSV Prophylaxis: Issues of Efficacy, Cost, and Evidence-Based Medicine , 2009, Pediatrics.

[13]  Mark J. Shlomchik,et al.  Maintenance of the plasma cell pool is independent of memory B cells , 2008, Proceedings of the National Academy of Sciences.

[14]  M. Chow,et al.  Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio , 2005, Journal of Virology.

[15]  F. Ennis,et al.  Human cytotoxic T-cell memory: long-lived responses to vaccinia virus , 1996, Journal of virology.

[16]  H. Whittle,et al.  Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal , 1995, The Pediatric infectious disease journal.

[17]  E. Paoletti,et al.  Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. , 1997, Virology.

[18]  A. Capra,et al.  Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response , 1992, The Pediatric infectious disease journal.

[19]  R. Effros,et al.  Challenges for vaccination in the elderly , 2007, Immunity & Ageing.

[20]  Dan R. Littman,et al.  The Role of CXCR4 in Maintaining Peripheral B Cell Compartments and Humoral Immunity , 2004, The Journal of experimental medicine.

[21]  Patricia W. Finn,et al.  Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life , 2002, The Journal of experimental medicine.

[22]  D. Watkins,et al.  Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge , 2009, Journal of Virology.

[23]  E. Wherry,et al.  Vaccines: Effector and memory T-cell differentiation: implications for vaccine development , 2002, Nature Reviews Immunology.

[24]  M. Mannie,et al.  Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. , 1999, Journal of immunology.

[25]  H. Salman,et al.  Measles vaccine failure. , 1991, Annals of Saudi medicine.

[26]  M. K. Mukherjee,et al.  The minimum protective level of antibodies in smallpox. , 1975, Bulletin of the World Health Organization.

[27]  R. Lechler,et al.  Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? , 2003, Blood.

[28]  D. Goldblatt,et al.  Immunological response to conjugate vaccines in infants: follow up study , 1998, BMJ.

[29]  Hermann Wagner,et al.  Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Deborah M. Brown,et al.  IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. , 2009, Cellular immunology.

[31]  Anthony D. Kelleher,et al.  Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.

[32]  S. Plotkin,et al.  1 – A short history of vaccination , 2013 .

[33]  Andreas Radbruch,et al.  Chemotactic Responsiveness Toward Ligands for CXCR3 and CXCR4 Is Regulated on Plasma Blasts During the Time Course of a Memory Immune Response1 , 2002, The Journal of Immunology.

[34]  C. Beadling,et al.  Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity , 2006, Nature Medicine.

[35]  S. Plotkin Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.

[36]  Andreas Radbruch,et al.  Plasma Cell Survival Is Mediated by Synergistic Effects of Cytokines and Adhesion-Dependent Signals1 , 2003, The Journal of Immunology.

[37]  S. Pierce,et al.  The tipping points in the initiation of B cell signalling: how small changes make big differences , 2010, Nature Reviews Immunology.

[38]  D. Maric,et al.  Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide–HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections , 2003, Nature Medicine.

[39]  S. Jameson,et al.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.

[40]  M. Goulon,et al.  [Antitetanus antibodies. Assay before anatoxinotherapy in 64 tetanus patients]. , 1972, La Nouvelle presse medicale.

[41]  J. Levy,et al.  A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines. , 1989, Journal of immunology.

[42]  P. Kinchington,et al.  Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. , 1991, Journal of immunology.

[43]  M. Frosch,et al.  Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. , 2001, Vaccine.

[44]  D. Lowy,et al.  Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles , 2004 .

[45]  S. Nutt,et al.  Terminal differentiation of lymphocytes depends on Blimp-1. , 2007, Current opinion in immunology.

[46]  J. McVernon,et al.  Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure , 2003, Archives of disease in childhood.

[47]  L. Picker,et al.  Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge , 2009, Nature Medicine.

[48]  Susan M. Kaech,et al.  Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .

[49]  M. Jackson,et al.  T Cells Can Use Either T Cell Receptor or Cd28 Receptors to Absorb and Internalize Cell Surface Molecules Derived from Antigen-Presenting Cells , 2000, The Journal of experimental medicine.

[50]  J. Kolls,et al.  Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  M. Gendron,et al.  HLA‐DR and ICAM‐1 Expression and Modulation in Epithelial Cells From Nasal Polyps , 2002, The Laryngoscope.

[52]  Andreas Radbruch,et al.  Lifetime of plasma cells in the bone marrow , 1997, Nature.

[53]  I. Kurane,et al.  Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. , 2005, Vaccine.

[54]  B. Murphy,et al.  Prospects for a dengue virus vaccine , 2007, Nature Reviews Microbiology.

[55]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[56]  J. Lang,et al.  A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. , 2010, The Journal of infectious diseases.

[57]  E. Joly,et al.  What is trogocytosis and what is its purpose? , 2003, Nature Immunology.

[58]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[59]  M. Hilleman,et al.  Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines. , 1975, Pediatrics.

[60]  M. Mannie,et al.  Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen‐presenting cells , 1997, European journal of immunology.

[61]  M. Slifka,et al.  Wanted, dead or alive: new viral vaccines. , 2009, Antiviral research.

[62]  H. Whittle,et al.  Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. , 1998, The Journal of clinical investigation.

[63]  R. Bram,et al.  BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.

[64]  P. Matricardi,et al.  Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles. , 1994, Journal of immunology.

[65]  B. Wiens,et al.  Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. , 1993, Journal of hepatology.

[66]  Rate of hemolytic antibody production by single cells in vivo in rabbits. , 1974, Journal of immunology.

[67]  J. Altman,et al.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.

[68]  R. Ahmed,et al.  SAP is required for generating long-term humoral immunity , 2003, Nature.

[69]  J. Eichberg,et al.  Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. , 1987, Journal of immunology.

[70]  R. Noelle,et al.  The immortality of humoral immunity , 2010, Immunological reviews.

[71]  R. Ahmed,et al.  Long-lived plasma cells: a mechanism for maintaining persistent antibody production. , 1998, Current opinion in immunology.

[72]  M Juliana McElrath,et al.  Induction of immunity to human immunodeficiency virus type-1 by vaccination. , 2010, Immunity.

[73]  R. Steinman,et al.  Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1 , 2000, The Journal of experimental medicine.

[74]  M. Birchall,et al.  Differential major histocompatibility complex class II locus expression on human laryngeal epithelium , 2003, Clinical and experimental immunology.

[75]  K. Schmader,et al.  Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. , 2009, The Journal of infectious diseases.

[76]  P. Bongrand,et al.  Intercellular transfer of antigen‐presenting cell determinants onto T cells: molecular mechanisms and biological significance , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  J. Heyse,et al.  Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection , 2002, The Pediatric infectious disease journal.

[78]  G. Prince,et al.  New insights for development of a safe and protective RSV vaccine , 2010, Human vaccines.

[79]  K. Früh,et al.  Cowpox Virus Evades CTL Recognition and Inhibits the Intracellular Transport of MHC Class I Molecules1 , 2007, The Journal of Immunology.

[80]  R. O. Spertzel,et al.  Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine , 1973, Applied microbiology.

[81]  M. Jackson,et al.  TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. , 1999, Science.

[82]  J. Cyster,et al.  A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements , 2001, The Journal of experimental medicine.

[83]  Sheng-I Chen,et al.  Single versus multi-dose vaccine vials: an economic computational model. , 2010, Vaccine.

[84]  P. Lambert,et al.  Can successful vaccines teach us how to induce efficient protective immune responses? , 2005, Nature Medicine.

[85]  S. Plotkin,et al.  Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[86]  W. Cox,et al.  Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. , 2000, The Journal of infectious diseases.

[87]  D. Schmid The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex. , 1988, Journal of immunology.

[88]  M. Greenberg LIVE POLIOVIRUS VACCINES , 1960 .

[89]  H. Whittle,et al.  Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages , 1995, The Lancet.

[90]  J. Miller,et al.  AN AUTORADIOGRAPHIC STUDY OF PLASMA CELL AND LYMPHOCYTE SURVIVAL IN RAT POPLITEAL LYMPH NODES. , 1964, Journal of immunology.

[91]  D. Thomas,et al.  A prospective study of serum antibody and protection against smallpox. , 1972, The American journal of tropical medicine and hygiene.

[92]  Taeg S. Kim,et al.  The Cell Cycle Time of CD8+ T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus , 2010, PloS one.

[93]  H. Whittle,et al.  What level of hepatitis B antibody is protective? , 1999, The Journal of infectious diseases.

[94]  R. Benner,et al.  The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. , 1981, Clinical and experimental immunology.

[95]  H. Eisen,et al.  The secretion of antibody by isolated lymph node cells. , 1961, The Journal of biological chemistry.

[96]  K. Calame,et al.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow , 2005, The Journal of experimental medicine.

[97]  D. Burton Antibodies, viruses and vaccines , 2002, Nature Reviews Immunology.

[98]  L. Matter,et al.  Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. , 1997, The Journal of infectious diseases.

[99]  T. McGaha,et al.  APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. , 2008, Blood.

[100]  F. Ennis,et al.  Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses1 , 2007, The Journal of Immunology.

[101]  W. Lim,et al.  The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers , 2003, Journal of viral hepatitis.

[102]  Robert T. Chen,et al.  Measles antibody: reevaluation of protective titers. , 1990, The Journal of infectious diseases.

[103]  M. Slifka,et al.  Mechanisms that determine plasma cell lifespan and the duration of humoral immunity , 2010, Immunological reviews.

[104]  H. Metzger,et al.  Transmembrane signaling: the joy of aggregation. , 1992, Journal of immunology.

[105]  B. Moss,et al.  Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens , 1992, Journal of virology.

[106]  E. Wherry,et al.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.

[107]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[108]  H. S. Kaye,et al.  Inactivated vaccines. 2. Laboratory indices of protection* , 1973 .

[109]  Nikhil S. Joshi,et al.  Differential Localization of Effector and Memory CD8 T Cell Subsets in Lymphoid Organs during Acute Viral Infection , 2010, The Journal of Immunology.

[110]  Michael J Beach,et al.  Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.

[111]  P. Aichele,et al.  T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections , 2010, European journal of immunology.

[112]  D. Moneret-vautrin,et al.  HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[113]  L P Skendzel,et al.  Rubella immunity. Defining the level of protective antibody. , 1996, American journal of clinical pathology.

[114]  Kenneth G. C. Smith,et al.  Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.

[115]  G. Hayden Measles vaccine failure. A survey of causes and means of prevention. , 1979, Clinical pediatrics.

[116]  O. Leo,et al.  Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature. , 2008, Gynecologic oncology.

[117]  A. Rosato,et al.  Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer , 2010, International reviews of immunology.

[118]  E. Joly,et al.  Cutting Edge: CTLs Rapidly Capture Membrane Fragments from Target Cells in a TCR Signaling-Dependent Manner1 , 2001, The Journal of Immunology.

[119]  M. Eibl,et al.  Antibodies protect mice against challenge with tick‐borne encephalitis virus (TBEV)‐infected macrophages , 1997, Clinical and experimental immunology.

[120]  Jan Holmgren,et al.  Mucosal immunity and vaccines , 2005, Nature Medicine.

[121]  H. Greenberg,et al.  Immunity and correlates of protection for rotavirus vaccines. , 2006, Vaccine.

[122]  B. Balbi,et al.  Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. , 1990, American journal of respiratory cell and molecular biology.

[123]  A. Casadevall Passive antibody therapies: progress and continuing challenges. , 1999, Clinical immunology.

[124]  M. Eibl History of immunoglobulin replacement. , 2008, Immunology and allergy clinics of North America.

[125]  W. Heath,et al.  Cutting Edge: Central Memory T Cells Do Not Show Accelerated Proliferation or Tissue Infiltration in Response to Localized Herpes Simplex Virus-1 Infection1 , 2006, The Journal of Immunology.

[126]  M. Sangster,et al.  Respiratory virus infection of mice provokes a permanent humoral immune response , 1994, Journal of virology.

[127]  Nichole E Carlson,et al.  Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.

[128]  Antonio Lanzavecchia,et al.  Antigen dependent and independent mechanisms that sustain serum antibody levels. , 2003, Vaccine.

[129]  A. Barrett,et al.  Yellow fever vaccine , 2005, Expert review of vaccines.

[130]  A. Hinman,et al.  Appropriate age for measles vaccination in the United States. , 1986, Developments in biological standardization.

[131]  I. Tizard Grease, anthraxgate, and kennel cough: a revisionist history of early veterinary vaccines. , 1999, Advances in veterinary medicine.

[132]  F. Klauschen,et al.  SAP-controlled T-B cell interactions underlie germinal centre formation , 2008, Nature.

[133]  R. Geha,et al.  Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL1 , 2008, The Journal of Immunology.

[134]  T. Braciale,et al.  Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection1 , 2004, The Journal of Immunology.

[135]  H. Hsu,et al.  Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. , 2003, The Journal of infectious diseases.

[136]  R. Germain,et al.  Acquisition of syngeneic I-A determinants by T cells proliferating in response to poly (Glu60Ala30Tyr10). , 1981, Journal of immunology.

[137]  D. Rock,et al.  Genome of Horsepox Virus , 2006, Journal of Virology.

[138]  B. Bell Hepatitis A vaccine. , 2002, Seminars in pediatric infectious diseases.

[139]  H. Eisen,et al.  Observations on the mechanism of secretion of gamma-globulins by isolated lymph node cells. , 1962, The Journal of biological chemistry.

[140]  R. Ahmed,et al.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. , 2004, Journal of immunological methods.

[141]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[142]  T. McKeithan,et al.  Peptide-Specific Intercellular Transfer of MHC Class II to CD4+ T Cells Directly from the Immunological Synapse upon Cellular Dissociation1 , 2005, The Journal of Immunology.

[143]  R. Ahmed,et al.  Bone marrow is a major site of long-term antibody production after acute viral infection , 1995, Journal of virology.

[144]  R. Welsh,et al.  Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection1 , 2005, The Journal of Immunology.

[145]  Hyun-Dong Chang,et al.  Organization and maintenance of immunological memory by stroma niches , 2009, European journal of immunology.

[146]  S. Kaech,et al.  Generation of effector CD8+ T cells and their conversion to memory T cells , 2010, Immunological reviews.

[147]  M. Leandro,et al.  Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[148]  M. Slifka,et al.  Longevity of T-cell memory following acute viral infection. , 2010, Advances in experimental medicine and biology.

[149]  D. Jelinek,et al.  Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation1 , 2007, The Journal of Immunology.

[150]  D. Romberger,et al.  Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells. , 2000, International journal of immunopharmacology.

[151]  P. Schneider,et al.  Cracking the BAFF code , 2009, Nature Reviews Immunology.

[152]  J. Whitton,et al.  Tentative T Cells: Memory Cells Are Quick to Respond, but Slow to Divide , 2008, PLoS pathogens.

[153]  Samuel L. Groseclose,et al.  Summary of Notifiable Diseases, United States. , 1997 .

[154]  I. Messaoudi,et al.  Protective immunity following vaccination: How is it defined? , 2008, Human vaccines.

[155]  A. Nussbaum,et al.  The Regulation and Maturation of Antiviral Immune Responses , 2004, Advances in Virus Research.

[156]  Thomas F. Tedder,et al.  Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice1 , 2008, The Journal of Immunology.

[157]  David C. Johnson,et al.  Human Cytomegalovirus US2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells , 2003, Journal of Virology.

[158]  L. Lefrançois Development, trafficking, and function of memory T‐cell subsets , 2006, Immunological reviews.

[159]  F. Fenner Smallpox and its eradication , 1988 .

[160]  Edward Jenner,et al.  An inquiry into the causes and effects of the Variolæ vaccinæ, 1798 , 1966 .